MedPath

COLORADO DENVER UNIVERSITY OF

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Effectiveness of Taking Choline Supplements During Pregnancy for Improving Infant Brain Development

Phase 1
Completed
Conditions
Pregnancy
Child Development
Interventions
Dietary Supplement: Placebo
Drug: Choline
First Posted Date
2006-06-01
Last Posted Date
2020-09-02
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
351
Registration Number
NCT00332124
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado Denver, Aurora, Colorado, United States

RCT of Mailed Brochure to Boost Adherence to Screening Colonoscopy

Not Applicable
Completed
Conditions
Mass Screening
Colonoscopy
First Posted Date
2006-03-29
Last Posted Date
2017-05-04
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
628
Registration Number
NCT00308568
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado at Denver and Health Sciences Center, Denver, Colorado, United States

Vitamin D Levels and Vitamin D Education in Geriatric Patients

Not Applicable
Completed
Conditions
Vitamin D Insufficiency
Vitamin D Deficiency
Interventions
Behavioral: Pharmacist Education about Vitamin D
First Posted Date
2006-01-09
Last Posted Date
2013-11-20
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
80
Registration Number
NCT00273611
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado Hospital Seniors Clinic, Aurora, Colorado, United States

Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients

Phase 1
Completed
Conditions
Schizophrenia
Psychotic Disorders
Interventions
Drug: Dimethoxybenzylidene anabaseine (DMXB-A)
Drug: Placebo
First Posted Date
2005-11-21
Last Posted Date
2015-07-01
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
12
Registration Number
NCT00255918
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado General Clinical Research Center, Denver, Colorado, United States

Effectiveness of an Online Prevention Program in Reducing the Risk of STD Infection in Young Adults

Not Applicable
Completed
Conditions
HIV Infections
Sexually Transmitted Diseases
Interventions
Behavioral: Youthnet Internet-based program
Behavioral: Control Internet based program
First Posted Date
2005-11-21
Last Posted Date
2020-10-05
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
2622
Registration Number
NCT00255944
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Internet-Based, accessible from anywhere, Bethesda, Maryland, United States

Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.

Phase 4
Completed
Conditions
Hyperlipidemia
Dyslipidemia
First Posted Date
2005-11-07
Last Posted Date
2017-03-28
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
60
Registration Number
NCT00249938
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado at Denver and Health Sciences Center, Denver, Colorado, United States

The Care Transitions Intervention

Not Applicable
Completed
Conditions
Continuity of Patient Care
First Posted Date
2005-10-26
Last Posted Date
2015-08-13
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
1400
Registration Number
NCT00244491
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado Health Sciences Center, Denver, Colorado, United States

Increasing Infant Preventive Health Service Delivery in an Inner City Population

Not Applicable
Terminated
Conditions
Healthy
Interventions
Behavioral: Reminder-Recall-Outreach
Behavioral: Case Management
Behavioral: Patient Navigator
First Posted Date
2005-09-22
Last Posted Date
2019-04-17
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
823
Registration Number
NCT00221507
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Denver Health Medical Center, Denver, Colorado, United States

A Tailored Interactive Website for Promoting Condom Use Among Young Adults

Phase 2
Completed
Conditions
HIV Infections
Sexually Transmitted Diseases
Interventions
Behavioral: Internet-based tailored prevention messages
Behavioral: Non-tailored messages
First Posted Date
2005-09-16
Last Posted Date
2013-11-27
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
1870
Registration Number
NCT00183638
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado Health Sciences Center, Aurora, Colorado, United States

Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia

Phase 3
Completed
Conditions
Schizophrenia
Interventions
Drug: Ondansetron followed by placebo
Drug: Placebo followed by Ondansetron
First Posted Date
2005-09-08
Last Posted Date
2021-08-13
Lead Sponsor
University of Colorado, Denver
Target Recruit Count
8
Registration Number
NCT00149734
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Denver VAMC, Denver, Colorado, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath